GILD rated highest in Twin Momentum Investor model for fundamental and price momentum.

From Nasdaq.: 2025-05-03 09:18:00

Validea’s guru fundamental report for Gilead Sciences Inc (GILD) shows it rates highest using the Twin Momentum Investor model by Dashan Huang, based on fundamental and price momentum. GILD is a large-cap growth stock in Biotechnology & Drugs, scoring 100% in this strategy. Huang’s paper combines traditional price momentum with improving fundamentals, identifying seven variables to measure fundamental momentum. Stocks in the top 20% of this measure outperform the market. Validea follows strategies of investment legends like Warren Buffett and Peter Lynch. GILD meets tests for fundamental and price momentum, indicating strong interest in the stock.



Read more at Nasdaq.: GILD Quantitative Stock Analysis | Nasdaq